NEW DELHI: India said on Sunday (Apr 11) it had banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients after a record spike in COVID-19 cases sent demand surging.
“In light of the above, Government of India has prohibited the exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the situation improves,” the health ministry said in a statement.
Seven Indian companies have licensed the drug from Gilead Sciences, with an installed capacity of about 3.9 million units per month.
READ: WHO advises against remdesivir for COVID-19 treatment
India reported a record 152,879 new COVID-19 cases, health ministry data showed on Sunday.
The number of new fatalities stood at 839, the most deaths in more than five months, taking the toll to 169,275.
BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments
Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram